The scope of the Azerbaijan Pharmaceutical and Pharmacotherapy Journal (APPJ) encompasses a broad range of topics within the fields of Pharmacology, Toxicology, Pharmaceutics and Medical Sciences. The journal welcomes submissions that cover, but are not limited to, the following areas:
-Drug discovery and development
-Clinical pharmacology and therapeutics
-Pharmacokinetics and pharmacodynamics
-Pharmacogenomics and personalized medicine
-Neuropharmacology
-Cardiovascular pharmacology
-Immunopharmacology
-Ethnopharmacology
-Pharmacovigilance and drug safety
-Herbal medicines and natural products
-Pharmaceutical biotechnology
-Pharmacoeconomics
-Environmental toxicology
-Occupational toxicology
-Toxicokinetics and toxicodynamics
-Toxicogenomics
-Chemical and drug toxicity
-Ecotoxicology
-Toxicity testing and risk assessment
-Toxicological mechanisms and biomarkers
-Regulatory toxicology
-Forensic toxicology
-Drug delivery systems
-Pharmaceutical formulation development
-Biopharmaceutics and pharmacokinetics
-Nanotechnology in drug delivery
-Pharmaceutical analysis and quality control
-Pharmaceutical technology and manufacturing
-Novel drug delivery approaches
-Pharmacokinetics and pharmacodynamics modeling
-Drug stability and degradation
-Pharmaceutical dosage forms
-Bioavailability and bioequivalence studies
-Clinical research and trials
-Medical biotechnology
-Molecular medicine
-Medical genetics and genomics
-Translational medicine
-Clinical pharmacy
-Pharmacotherapy
-Precision medicine
The journal encourages the submission of original research articles, reviews, and case reports that contribute to the understanding and advancement of pharmacology, toxicology, and pharmaceutics. It provides a platform for researchers to present their findings, share innovative methodologies, and discuss current challenges and future directions in the field.
The target audience of Azerbaijan Pharmaceutical and Pharmacotherapy Journal includes researchers, academicians, pharmacists, toxicologists, medical scientists, pharmaceutical industry professionals, healthcare providers, regulatory authorities, and other stakeholders interested in the latest developments and advancements in pharmacology, toxicology, and pharmaceutics. The journal aims to foster collaboration, knowledge exchange, and scientific progress in these fields, ultimately contributing to improved healthcare outcomes and drug development practices.
